An Open-Label Safety Study of A-101 Solution
Clinical trial NCT02667288 · COMPLETED
Trial details
- NCT number
- NCT02667288
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-10-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.